Main Page Article Search E-Lerts™ Newsletter: Current E-Lerts™ Newsletter Archives E-Lerts™ Newsletter Recipes Archives Defeat Diabetes® E-Lerts™ Newsletter Subscribe Defeat Diabetes ® News by Daniel H. Rasolt Books You Can Use™ Subscribe to Defeat Diabetes Foundation Mailings
About Diabetes Body Care Children Complications Defeat Diabetes Foundation Drugs    » ACE Inhibitor    » Actos    » Alternative Medicine    » Aspirin    » Avandia    » Byetta    » Drugs    » Exenatide    » Glargine    » Glucophage    » Insulin    » Januvia    » Lantus    » Liraglutide    » Metformin    » Recall    » Research    » Rosiglitazone    » Self-Management    » Statins    » Sulfonylureas    » Victoza Elderly E-Lerts™ Governments & Organizations Health & Fitness Insulin MADDCAP™ Mr. Diabetes® Nutrition Obesity Other Diseases Pregnancy Research Risks Self-Management Supplements Type 1 Warning Signs

 

 

 

     

Drugs

Search our News Articles Archives for diabetes and health news. Search by word or phrase.  The latest article will appear first.

Search For:  

Search in all categories / subcategories
Search in current category / subcategory

Diabetes Drug ACTOS Protects Brain from Radiation Therapy Posted: Thursday, January 18, 2007

Researchers have reported that in animal studies, Actos prevented memory and learning problems associated with cancer radiation treatments on the brain.

New Drug Shows Promise Against Diabetic Eye Condition Posted: Wednesday, January 10, 2007

A new study suggests that eye injections of the drug Lucentis (also known as ranibizumab) appear to be useful in the treatment of a potentially blinding eye condition called macular edema that can afflict people with diabetes.

Diabetes Drug Reverses SGA-Related Weight Gain Posted: Wednesday, January 10, 2007

Taking metformin with antipsychotic drugs, may counteract the weight gain and possible diagnosis of diabetes.

Drug Treatment Slows Macular Vision Loss in Diabetics Posted: Thursday, December 28, 2006

A drug commonly used to slow the loss of central vision has shown promise in stemming a common precursor of blindness in diabetics, which involves the same central light-sensitive area of retina, scientists report.

Statin Users Risk Heart Attack by Dropping Drugs or Taking Low Doses Posted: Thursday, December 21, 2006

Projects 5-7,000 Americans yearly suffer unnecessary heart attacks.

Alternate-day Dosing of Statins in Type 2 Diabetic Patients with Dyslipidemia Posted: Thursday, December 21, 2006

Alternate-day dosing of atorvastatin could be an effective and safe alternative to daily-dosing in some type 2 diabetic patients.

'Double Diabetes' a New Threat: 1 Plus 2 Equals 3 Posted: Thursday, December 14, 2006

The obesity epidemic is leading more people to develop type 1 and type 2 diabetes disease.

Oral Steroids Trigger 2% of All New Cases of Diabetes Posted: Thursday, December 14, 2006

Researchers in the December issue of Diabetes Care, found that the use of oral steroids can be a precipitating factor in some cases of new-onset diabetes.

New Data Shows Sitagliptin + Metformin Reduces Both Prandial and Fasting Blood Glucose Posted: Thursday, December 14, 2006

Data Support JANUMET™, an Investigational Combination Therapy of Sitagliptin Phosphate Plus Metformin for Type 2 Diabetes Initial treatment with sitagliptin phosphate 50 mg twice daily in combination with metformin 1,000 mg twice daily provided substantial reductions of post prandial, or post-meal, glucose (PPG) levels and fasting plasma glucose (FPG) levels in patients with type 2 diabetes, according to new data.

Diet Drug Acomplia (Rimonabant) Lowers Blood Sugars and Reduces Weight Posted: Thursday, December 14, 2006

New study results show patients with an HbA1c level of at least 8.5 when they started taking Acomplia saw their their blood sugar level decrease 1.9 points compared to 0.7 points in patients on a placebo.

 

 

 

 

 

 Costa Rica Travel Corp. will donate a portion of the proceeds to and is a sponsor of Defeat Diabetes Foundation.